GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

Published:2013-03-31 Issue:5 Volume:19 Page:567-575
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kim Minsuk,Platt Mathew J,Shibasaki Tadao,Quaggin Susan E,Backx Peter H,Seino Susumu,Simpson Jeremy A,Drucker Daniel J

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3128.pdf

Reference44 articles.

1. Goldfine, A.B. Assessing the cardiovascular safety of diabetes therapies. N. Engl. J. Med. 359, 1092–1095 (2008).

2. Fonseca, V.A., Zinman, B., Nauck, M.A., Goldfine, A.B. & Plutzky, J. Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am. J. Med. 123, S2–S10 (2010).

3. Sivertsen, J., Rosenmeier, J., Holst, J.J. & Vilsboll, T. The effect of glucagon-like peptide 1 on cardiovascular risk. Nat. Rev. Cardiol. 9, 209–222 (2012).

4. Fonseca, V.A. Ongoing clinical trials evaluating the cardiovascular safety and efficacy of therapeutic approaches to diabetes mellitus. Am. J. Cardiol. 108, 52B–58B (2011).

5. Ussher, J.R. & Drucker, D.J. Cardiovascular biology of the incretin system. Endocr. Rev. 33, 187–215 (2012).

Cited by 402 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a high-yield recombinant clone for the enhanced production of a long-acting Glucagon like peptide-1 analogue with improved biological efficacy;Process Biochemistry;2024-12

2. The weight reduction mediated by anti-obesity medication and the cardiovascular outcome;iScience;2024-10

3. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

4. Contractile Effects of Semaglutide in the Human Atrium;Pharmaceutics;2024-08-28

5. Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges;European Journal of Pharmacology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3